Epitalon programA plain-language guide to care questions Chapter index

A withdrawn ingredient request

Can a pharmacy make epitalon medicine?

This page follows a request to add epitalon to the list of ingredients pharmacies may use. The people who submitted it later took it back.

The myth

Taking back the request gives pharmacies permission to make epitalon.

Where the promise meets evidence

As of September 28, 2026, withdrawing the request had not cleared epitalon for pharmacies to make into medicine.

What was requested, and what changed

Compounding makes a medicine to order instead of supplying a finished factory product.

The request asked the FDA, the US drug agency, to allow epitalon as a pharmacy ingredient. The FDA page records this request as withdrawn, meaning taken back, and is marked current as of April 22, 2026.

The same FDA entry still warns about possible harm from epitalon.

The page does not give the date when the request was taken back.

Why a meeting did not change the rules

Before the July 24, 2026 discussion, FDA staff had recommended against adding epitalon to the allowed-ingredient list.

A group of advisers discussed epitalon at the July 24, 2026 meeting. By September 28, 2026, the FDA had published no official record of their votes.

The rules checked on September 26, 2026 say the advisers’ vote only gives advice. To change the ingredient list, the FDA must propose a rule and invite public comments before making the rule final.

A headline about the meeting does not tell you that the rule has changed. Ask for the final rule.

Two different lists to check

As of September 28, 2026, epitalon was not on the FDA’s official list of allowed pharmacy ingredients. It was also missing from the temporary list for ingredients still under review.

The temporary list is called Category 1. Under the policy checked on September 26, 2026, the FDA says it will leave pharmacies alone for certain uses of ingredients on that list. Pharmacies must also follow the policy’s rules for making medicines. The list alone is not enough. This says when the FDA plans to leave pharmacies alone. It does not give drug approval or say that every use is lawful.

For example, a regular pharmacy must make the medicine for a particular person who has a prescription. That rule was checked on September 26, 2026. Other rules also apply.

Epitalon was not on that temporary list, as of September 28, 2026. The policy therefore did not cover it.

If an offer relies on a new rule, ask for the official rule and its date. Ask what it actually permits for the product being offered.